Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Oberguggenberger Anne S"'
Autor:
Schmalz, Claudia1 claudia.schmalz@uksh.de, Oberguggenberger, Anne S.2, Nagele, Eva3, Bliem, Brigitte3, Lanceley, Anne4, Nordin, Andy5, Kuljanic, Karin6, Jensen, Pernille T.7, Bjelic-Radisic, Vesna8, Fabian, Alexander1, Arraras, Juan I.9, Wei-Chu, Chie10, Creutzberg, Carien L.11, Galalae, Razvan12, Toelen, Hilde13, Zimmermann, Kristin14, Costantini, Anna15, Almont, Thierry16, Serpentini, Samantha17, Frøding, Ligita Paskeviciute18
Publikováno v:
BMC Palliative Care. 7/29/2024, Vol. 23 Issue 1, p1-7. 7p.
Autor:
Holzner Bernhard, Giesinger Johannes M, Pinggera Jakob, Zugal Stefan, Schöpf Felix, Oberguggenberger Anne S, Gamper Eva M, Zabernigg August, Weber Barbara, Rumpold Gerhard
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 12, Iss 1, p 126 (2012)
Abstract Background Patient-reported Outcomes (PROs) capturing e.g., quality of life, fatigue, depression, medication side-effects or disease symptoms, have become important outcome parameters in medical research and daily clinical practice. Electron
Externí odkaz:
https://doaj.org/article/6891dbe9454b4669b799aa8a1d7f482c
Autor:
Oberguggenberger Anne S, Sztankay Monika, Beer Beate, Schubert Birthe, Meraner Verena, Oberacher Herbert, Kemmler Georg, Giesinger Johannes, Gamper Eva, Sperner-Unterweger Barbara, Marth Christian, Holzner Bernhard, Hubalek Michael
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 474 (2012)
Abstract Background Current studies on adherence to endocrine therapy in breast cancer patients suffer from methodological limitations due to a lack of well-validated methods for assessing adherence. There is no gold standard for measuring adherence.
Externí odkaz:
https://doaj.org/article/ae1f2d94f2ab4279976e3ef22182a9ad
Autor:
Oberguggenberger Anne S, King Madeleine T, Kemmler Georg, Gamper Eva M, Conroy Thierry, Arraras Juan I, Aaronson Neil K, Groenvold Mogens, Aa Petersen Morten, Giesinger Johannes M, Velikova Galina, Young Teresa, Holzner Bernhard
Publikováno v:
Health and Quality of Life Outcomes, Vol 9, Iss 1, p 19 (2011)
Abstract Introduction Within an ongoing project of the EORTC Quality of Life Group, we are developing computerized adaptive test (CAT) measures for the QLQ-C30 scales. These new CAT measures are conceptualised to reflect the same constructs as the QL
Externí odkaz:
https://doaj.org/article/9b1811588b354c8e8b40fb445dd5ffd0
Autor:
Greimel, Elfriede, Nagele, Eva, Lanceley, Anne, Oberguggenberger, Anne S., Nordin, Andy, Kuljanic, Karin, Arraras, Juan I., Wei-Chu, Chie, Jensen, Pernille T., Tomaszewski, Krzysztof A., Creutzberg, Carien L., Galalae, Razvan, Toelen, Hilde, Zimmermann, Kristin, Bjelic-Radisic, Vesna, Costantini, Anna, Almont, Thierry, Serpentini, Samantha, Paskeviciute Frøding, Ligita, Vistad, Ingvild, Schmalz, Claudia
Publikováno v:
In European Journal of Cancer September 2021 154:235-245
Autor:
Holzner, Bernhard, Efficace, Fabio, Basso, Umberto, Johnson, Colin D., Aaronson, Neil K., Arraras, Juan I., Smith, Allan B., Chow, Edward, Oberguggenberger, Anne S., Bottomley, Andrew, Steiner, Hannes, Incrocci, Luca, Giesinger, Johannes M.
Publikováno v:
Quality of Life Research, 2013 Mar 01. 22(2), 369-378.
Externí odkaz:
https://www.jstor.org/stable/24722711
Autor:
Sztankay, Monika, Aaronson, Neil K., Arraras, Juan I., Basso, Umberto, Bumbasirevic, Uros, Efficace, Fabio, Giesinger, Johannes M., Johnson, Colin D., van Leeuwen, Marieke, Oberguggenberger, Anne S., Sosnowski, Roman, Young, Teresa, Holzner, Bernhard
BACKGROUND: Given the high cure-rate for testicular cancer (TC) and the patients' young age, comprehensive evaluation of health-related quality of life (HRQOL) is an important consideration in this patient population. The EORTC QLQ-TC26 questionnaire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::e1483b48b7d75b707e4f83591dcf8e3b
https://eprints.soton.ac.uk/426505/
https://eprints.soton.ac.uk/426505/
Autor:
Giesinger, Johannes M, Wintner, Lisa M, Zabernigg, August, Gamper, Eva-Maria, Oberguggenberger, Anne S, Sztankay, Monika J, Kemmler, Georg, Holzner, Bernhard
Publikováno v:
BMC Cancer
Background In chemotherapy trials quality of life (QOL) is assessed mostly at the days of chemotherapy administration (i.e. event-driven) during treatment and follows fixed time intervals in the aftercare phase (i.e. time-driven). Specific QOL impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d6c4204e4767804cbbc9c8b4523e871c
http://europepmc.org/articles/PMC4198707
http://europepmc.org/articles/PMC4198707
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.